Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company's primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. Its technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.
|Headquarters||Suite D, 5835 Peachtree Corners East|
NORCROSS, GA, United States 30092
|Chairman of the Board||Michael James|
|Chief Executive Officer||Gene Cartwright|
|Independent Vice Chairman of the Board||Ronald Hart|
|Senior Vice President - Engineering||Richard Fowler|
|Independent Director||John Imhoff|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P Capital IQ, INK and Argus.
|Shares Out.||66.3M||Book Value||$0.02|
|Guided Therapeutics Inc does not pay a dividend.||P/E||--|
|P/Cash Flow (TTM)||--|
*GAAP = prior to non-GAAP analyst adjusted earnings.